Experimental Biology And Medicine | Finanzwire

Basculer en Français

11189	Companies
247545	Keywords
175382	Articles
133776	Press releases

Headlines Articles Press releases Experimental Biology And Medicine

Home
Companies
Experimental Biology And Medicine

BRIEF

published on 06/18/2024 at 15:05, 2 years 3 months ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye

Diabetic Dry Eye Naltrexone Tear Production OGF-OGFr Pathway Ocular Complications
PRESS RELEASE

published on 06/18/2024 at 15:00, 2 years 3 months ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye
Study led by Dr. Pat McLaughlin reveals topical naltrexone's effectiveness in reversing dry eye in diabetic rats. Findings point to OGF-OGFr pathway blockade as a promising treatment approach

Diabetes Experimental Biology And Medicine Naltrexone OGF-OGFr Pathway Dry Eye
BRIEF

published on 04/03/2024 at 15:05, 2 years 6 months ago

HTERT Vaccine Shows Promise in Therapy-Resistant Cancer Patients, Study Finds

Cancer Immunotherapy HTERT Vaccination Therapy-resistant Cancer Immune Response King's College London
PRESS RELEASE

published on 04/03/2024 at 15:00, 2 years 6 months ago

Study Shows hTERT Vaccination Induces Immunological Responses and Prevents Progression in a Subset of Therapy-Resistant Poor Prognosis Cancer Patients
A Phase 1 clinical trial led by James Spicer at King's College London showcases promising developments in immune therapy for solid tumours via hTERT vaccination. Published in Experimental Biology and Medicine

Solid Tumors Clinical Trial HTERT Vaccination Immune Therapy Experimental Biology And Medicine

Accesswire

Published on 10/17/2026 at 03:20, 6 hours 13 minutes ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 6 hours 18 minutes ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 9 hours 58 minutes ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 10 hours 3 minutes ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 10 hours 33 minutes ago

Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE

EQS Group

Published on 10/16/2026 at 20:08, 13 hours 24 minutes ago

EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 14 hours 12 minutes ago

Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 14 hours 27 minutes ago

Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 15 hours 14 minutes ago

Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 15 hours 19 minutes ago

EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance

Les Echos

Published on 10/16/2026 at 18:48, 14 hours 44 minutes ago

Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 07:30, 1 day 2 hours ago

Third Quarter Revenues 2026
Published on 10/15/2026 at 18:50, 1 day 14 hours ago

September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 1 day 15 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 17:45, 1 day 15 hours ago

VOGO : H1 2026 results.

View all LES ECHOS COMFI WIRE